News | November 6, 2024
Devyser at 20: Celebrating two decades of innovation in genetic diagnostics
Find out more
Admin
Devyser Compact achieves Class III approval in China
Devyser to share data at ASHI 2024 demonstrating its innovations and studies within transplantation
Streamlining familial hypercholesterolemia testing: How Sahlgrenska University Hospital laboratory optimized workflow with Devyser FH
New insights into thalassemia: Latest studies using Devyser Thalassemia for NGS testing
Devyser Diagnostics AB publishes quarterly report for the period April to June 2024
“Devyser continued to report high sales growth in the second quarter. Organic growth compared with...
Devyser wins tender in Italy for its cystic fibrosis NGS test worth up to 5.9 million SEK
Meeting Modern Demands: Overcoming Thalassemia Testing Challenges with NGS
One-size-fits-all: Addressing hemoglobinopathy using NGS
Devyser wins tender in Sweden for Thalassemia NGS testing worth up to 8.4 million SEK
Streamlining Thalassemia Genetic Testing with NGS: Insights from Cyprus
